The COVID-19 pandemic influenced cancer incidence.
Freenome Raises $254M to Accelerate Early Cancer Detection Platform
What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative